Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2000
06/28/2000EP1011673A1 Novel niddm regimen
06/28/2000EP1011669A1 Inhibitors of farnesyl-protein transferase
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP1011666A1 Antithrombotic agents
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000EP1011662A1 Improved compositions and methods for the control of smoking
06/28/2000EP1011659A2 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid
06/28/2000EP1011655A1 Inhibitors of leaderless protein export
06/28/2000EP1011653A1 Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
06/28/2000EP1011648A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
06/28/2000EP1011635A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
06/28/2000EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
06/28/2000EP1011346A1 Animal feed containing carboxylic acids
06/28/2000EP1011330A1 Central nervous system axon regeneration
06/28/2000EP0915710B1 Stable radioiodine conjugates and methods for their synthesis
06/28/2000EP0833899A4 Cis-9,10-octadecenoamidase
06/28/2000EP0808318B1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258290A Salt
06/28/2000CN1258280A Cyanoamidines as cell proliferation inhibitors
06/28/2000CN1258279A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258277A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258276A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258219A Benzocycloheptathiophene compounds
06/28/2000CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same
06/28/2000CN1257705A Flowable drug precursor product for compressing tablet, pill and coated tablet, and preparing method thereof
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/28/2000CN1053834C Health medicinal liquor for discotinuing habit of smoking and detoxifying, and producing process thereof
06/27/2000US6080873 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
06/27/2000US6080871 Sulfonamides and sulfamides as H3 receptor antagonists
06/27/2000US6080866 A chemical intermediates for endothelin receptor antagonists
06/27/2000US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants
06/27/2000US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction
06/27/2000US6080782 Cyclohexyl dihydrobenzofuranes
06/27/2000US6080778 Methods for decreasing beta amyloid protein
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080773 Benzylamine derivatives which are useful in treating psychiatric disorders
06/27/2000US6080769 Imidazolidin-4-one derivatives useful as anticancer agents
06/27/2000US6080768 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
06/27/2000US6080765 Pharmaceutical composition
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080761 Inhibition of smooth muscle cell migration by (R)-amlodipine
06/27/2000US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis
06/27/2000US6080756 Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080752 For treating condition which requires antagonism of a dopamine receptor such as psychtic condition
06/27/2000US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia
06/27/2000US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
06/27/2000US6080740 Spiro-ketal derivatives and their use as therapeutic agents
06/27/2000US6080721 Pulmonary delivery of active fragments of parathyroid hormone
06/27/2000US6080720 Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3)
06/27/2000US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling
06/27/2000US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide
06/27/2000US6080579 Method for producing human intervertebral disc cells
06/27/2000US6080558 Polynucleotide encoding human growth regulator protein
06/27/2000US6080431 Nutritional mineral supplements comprising calcium citrate malate and vitamin d; for increasing bone growth and for treating age-related bone loss in humans and animals
06/27/2000US6080407 Diagnostic assays for MIF
06/27/2000US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity
06/27/2000CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia
06/27/2000CA2188427C Neurotransmitter release enhancers
06/22/2000WO2000036352A1 Flowable, ready-to-be-compressed medical intermediate products for tablets, pellets and dragees and method for producing the same
06/22/2000WO2000036113A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036099A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
06/22/2000WO2000036090A2 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells
06/22/2000WO2000035948A1 Methods and compositions for treating disorders involving excitotoxicity
06/22/2000WO2000035946A1 Methods
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035921A1 4,5-pyrazinoxindoles as protein kinase inhibitors
06/22/2000WO2000035919A2 Quinoline derivatives
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035911A1 Heteroaryl-cyclic acetals
06/22/2000WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000WO2000035900A1 Optical molecular sensors for cytochrome p450 activity
06/22/2000WO2000035892A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000WO2000035891A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
06/22/2000WO2000035878A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000WO2000035874A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
06/22/2000WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors
06/22/2000WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
06/22/2000WO2000035856A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035848A1 Aldose reductase inhibitors and pharmaceutical compositions
06/22/2000WO2000035484A2 Methods and compositions for decreasing allergic reactions to surface allergens
06/22/2000WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation
06/22/2000WO2000035462A1 Novel therapeutic application of low molecular weight heparin
06/22/2000WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE
1 ... 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 ... 1564